VTE Incidence in Severe Sepsis and Septic Shock
VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock
1 other identifier
observational
113
0 countries
N/A
Brief Summary
Prospective studies on the incidence of VTE during severe sepsis and septic shock remain absent, hindering efficacy assessments regarding current VTE prevention strategies in septic patients. The investigators will prospectively study consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients will provide informed consent and the study will be IRB approved. VTE thromboprophylaxis, provided per standard of care and according to the patients' primary team, will be recorded for all patients. Patients will undergo bilateral lower (and upper, if a central venous catheter \[CVC\] was present) comprehensive compression ultrasonography (CUS) and will be followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. The investigators will perform multivariate regression analyses to identify predictors of VTE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 23, 2015
CompletedFirst Posted
Study publicly available on registry
February 3, 2015
CompletedFebruary 3, 2015
January 1, 2015
5.4 years
January 23, 2015
February 2, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of VTE
28 days
Interventions
Eligibility Criteria
We prospectively studied 113 consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients provided informed consent and this study was IRB approved. VTE thromboprophylaxis was recorded for all patients. Patients underwent bilateral lower (and upper, if a central venous catheter \[CVC\] was present) comprehensive compression ultrasonography (CUS) and were followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. We performed multivariate regression analyses to identify predictors of VTE
You may qualify if:
- ICU patients with severe sepsis and septic shock
You may not qualify if:
- Admission diagnosis of acute VTE,
- age \< 13 years,
- pregnancy,
- severe chronic respiratory disease,
- severe chronic liver disease (Child-Pugh Score of 11-15),
- moribund patients not expected to survive 24 hours, and
- acute myocardial infarction within 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Institutes of Health (NIH)collaborator
Related Publications (1)
Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, Weyrich AS, Grissom CK, Zimmerman GA, Rondina MT. VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest. 2015 Nov;148(5):1224-1230. doi: 10.1378/chest.15-0287.
PMID: 26111103DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 23, 2015
First Posted
February 3, 2015
Study Start
July 1, 2009
Primary Completion
December 1, 2014
Last Updated
February 3, 2015
Record last verified: 2015-01